September 2024: NEI Member News and CME/CE Releases

September 2024: NEI Member News and CME/CE Releases

NEI Members have exclusive access to practical point-of-care resources and an extensive library of online content, all designed to help you stay current in your clinical practice. Expand your knowledge of psychopharmacology in a clinically relevant fashion. Not yet an NEI Member? Join now to gain this valuable resource.

Read the latest news and research updates that took place This Month in Psychopharmacology:

> FDA Approves First Muscarinic Agonist for Schizophrenia

> Sleep Disturbances and Antidepressant Response in Older Adults with Treatment-Resistant Late-Life Depression

> Mortality Risk In Long-Acting Injectable Versus Oral Antipsychotics In Schizophrenia

> Smoking Cessation as a Priority for Psychiatrists

View Additional Articles


An NEI Member exclusive– Mechanism of Action are narrated animations that break down the complexity of psychopharmacologic concepts.

With a new muscarinic agonist FDA approved for the treatment of schizophrenia in adults, NEI Members can watch this four-part Mechanism of Action (MOA) animation series to learn about how procholinergic treatments for schizophrenia. In these animation, the intricate neurocircuitry affecting dopaminergic neurotransmission are be explored. With this understanding, potential utilization and advantages of muscarinic agents to modulate dopamine levels without directly affecting dopamine D2 receptors will be elucidated.

Procholinergic Treatments for Schizophrenia: How Do They Work?


Have you started the 2024-26 NEI Master Psychopharmacology Program yet?

The Master Psychopharmacology Program is included with NEI Membership. Join the distinguished list of mental health professionals who have earned the Master Psychopharmacology Program certificate!

A 49-Year-Old Woman With Symptoms of Depression During Perimenopause (case, CME/CE)*

Pharmacological Treatment Options for Borderline Personality Disorder (video, CME/CE)* 

*Counts toward the Master Psychopharmacology Program requirements.

We’ve added medications to NEI Prescribe, and more are on the way! Make sure you keep the app up to date on your mobile device so you always have the latest information. 

The visual language of Stahl’s Essential Psychopharmacology is brought to life in this high-impact learning format designed for both students and mental health professionals eager to understand the neuroscientific basis of mental illness and its treatment. Each 30–45-minute video features Dr. Stephen M. Stahl, MD, PhD, DSc as he conveys the fundamentals of psychopharmacology through fully animated illustrations.

Stahl's Essential Videos are a Membership feature designed to help you master the fundamentals of psychopharmacology. Not a member? – learn me about pricing


Essential psychopharmacology brought to life online!

NEI Member Tips and Pearls provides highlights and updated prescribing information for key psychotropic treatments. This month, find tips and pearls for Gepirone ER, an antidepressant that modulates serotonergic neurotransmission as a selective partial agonist at the serotonin 1A receptor.

>> Gepirone ER

NEI Membership gives you exclusive access to practical point-of-care resources, an extensive library of online content, and significant discounts on registration to our annual conferences, all designed to help you stay current in your clinical practice.

Not yet a Member? Join today














To view or add a comment, sign in

Insights from the community

Explore topics